Personal profile
Fields of Science
- 3111 Biomedicine
Collaborations and top research areas from the last five years
-
Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT
Lahtinen, A. K., Karu, M., Koski, J. R., Ritari, J., Hyvärinen, K., Koskela, S., Nihtilä, J., Partanen, J., Vettenranta, K., Koskenvuo, M., Niittyvuopio, R., Salmenniemi, U., Itälä-Remes, M., Jahnukainen, K., Kilpivaara, O. & Wartiovaara-Kautto, U., Aug 2025, In: British Journal of Haematology. 207, 2, p. 636-641 6 p.Research output: Contribution to journal › Letter › Scientific
Open AccessFile -
Mutational signatures and their association with cancer survival and gene expression in multiple cancer types
Karihtala, P., Kilpivaara, O. & Porvari, K., 1 Jan 2025, In: International Journal of Cancer. 156, 1, p. 114-129 16 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms
Baliakas, P., Tesi, B., Cammenga, J., Stray-Pedersen, A., Jahnukainen, K., Andersen, M. K., Ågerstam, H., Creignou, M., Dybedal, I., Raaschou-Jensen, K., Grønbæk, K., Kilpivaara, O., Hellström Lindberg, E. & Wartiovaara-Kautto, U., Aug 2024, In: Hemasphere. 8, 8, 5 p., e145.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
NFKB1-geenin variantit altistavat nekrotisoivalle faskiitille
Translated title of the contribution :Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis Research output: Contribution to journal › Comment/debate › Professional
Open AccessFile -
Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis
Nurmi, A. K., Silventoinen, K., Keskitalo, S., Rajamäki, K., Kouri, V.-P., Kinnunen, M., Jalil, S., Sartori-Maldonado , R., Wartiovaara, K., Nievas, E. I., Denita-Juárez, S. P., Duncan, C. J. A., Kuismin, O., Saarela, J., Romo, I., Martelius, T., Parantainen, J. T., Beklen, A., Bilicka, M. & Matikainen, S. & 12 others, , 16 Apr 2024, In: Cell Reports Medicine. 5, 4, 29 p., 101503.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
Projects
- 3 Active
-
Juselius 24-25_Kilpivaara_Wartiovaara-Ka
Kilpivaara, O. (Project manager), Douglas, S. (Participant), Ikonen, I. K. (Participant), Kaaja, I. M. (Participant), Katainen, E. L. K. (Participant), Koski, J.R.-M. (Participant), Räisänen, T. H. (Participant) & Torniainen, K. T. (Participant)
Sigrid Juséliuksen Säätiö @003701165704@
01/05/2024 → 30/04/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Syöpäsäätiö 2023-24_Kilpivaara Outi
Kilpivaara, O. (Project manager), Koski, J.R.-M. (Participant), London, A. L. (Participant), Räisänen, T. H. (Participant) & Torniainen, K. T. (Participant)
Syöpäsäätiö sr Cancerstiftelsen sr
01/01/2023 → 31/03/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Uusia näkemyksiä leukemian syntyyn
Kilpivaara, O. (Project manager), Douglas, S. (Participant), Ikonen, I. K. (Participant), Katainen, E. L. K. (Participant), Koski, J.R.-M. (Participant), Langohr, L. (Participant) & Torniainen, K. T. (Participant)
01/09/2022 → 31/08/2026
Project: Research Council of Finland: Academy Project